Susquehanna International Group’s InspireMD NSPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-24,716
Closed -$81.1K 13000
2023
Q3
$81.1K Buy
+24,716
New +$78.9K ﹤0.01% 11064
2022
Q4
Sell
-15,730
Closed -$23K 13276
2022
Q3
$23K Buy
+15,730
New +$28.7K ﹤0.01% 12553
2022
Q2
Sell
-13,103
Closed -$42K 13602
2022
Q1
$42K Buy
13,103
+2,292
+21% +$6.35K ﹤0.01% 12385
2021
Q4
$33K Buy
+10,811
New +$40.6K ﹤0.01% 12718
2020
Q4
Sell
-1,086
Closed -$5K 11502
2020
Q3
$5K Sell
1,086
-456
-30% -$2.89K ﹤0.01% 10442
2020
Q2
$11K Buy
+1,542
New +$15.7K ﹤0.01% 9975
2016
Q4
Hold
0
-$15K 9950
2016
Q3
Hold
0
8267
2015
Q3
Hold
0
-$15K 9986
2015
Q2
Hold
0
10018
2015
Q1
Hold
0
9333

Other funds holding NSPR

Susquehanna International Group's NSPR Position: Q4 2023 in Review

Susquehanna International Group sold out of InspireMD (NSPR) in Q4 2023, closing a stake of 24,716 shares — an estimated $81.1K sold.

Susquehanna International Group first reported a position in NSPR in Q2 2020 and held it in 6 quarters. The position peaked at $81.1K in Q3 2023. 29 funds tracked by Wall St. Rank hold NSPR as of Q4 2023.

  • Susquehanna International Group reported no remaining InspireMD position as of Q4 2023 after selling out during the quarter.
  • Susquehanna International Group sold 24,716 InspireMD shares in Q4 2023, an estimated $81.1K.
  • Susquehanna International Group first reported a position in InspireMD in Q2 2020 and held it in 6 quarters.
  • Susquehanna International Group's InspireMD position peaked at $81.1K in Q3 2023.
  • 29 funds tracked by Wall St. Rank held InspireMD as of Q4 2023.

Based on Susquehanna International Group's 13F filing for Q4 2023, filed 14 Feb 2024.